Sage Journals: Discover world-class research

Open access

Research article

First published 2022-1

Synthesis and Evaluation of Acylated Derivatives of Hederagenin as Inhibitors of HIV-1 and HCV NS3/4A Proteases

Qing Liu, Ying Wei, Yongjia Hao [...]

Natural Product Communications

Free access

Research article

First published 2018-5

Characterization of HCV Resistance from a 3-Day Monotherapy Study of Voxilaprevir,a Novel Pangenotypic NS3/4A Protease Inhibitor

Eric Lawitz, Jenny C Yang, Luisa M Stamm [...]

Antiviral Therapy

Retricted access

Research article

First published 2005-08

High-Throughput Cell-Based Screening for Hepatitis C Virus NS3/4A Protease Inhibitors

Jin-Ching Lee, Ming-Chen Yu, Tzu-Wen Lien [...]

ASSAY and Drug Development Technologies

Free access

Research article

First published 2008-5

Mapping Natural Polymorphisms of Hepatitis C virus NS3/4A Protease and Antiviral Resistance to Inhibitors in Worldwide Isolates

F Xavier López-Labrador, Andrés Moya, Fernando Gonzàlez-Candelas

Antiviral Therapy

Open access

Letter

First published 2018

A study on the relationship between HCV NS3 and endogenous IRF-3

Hong-Ping Liang, Hotta Hak, Jian-Min Ji

European Journal of Inflammation

Free access

Research article

First published 2001-12

Inhibition of the Bovine Viral Diarrhoea Virus NS3 Serine Protease by a Boron-Modified Peptidyl Mimetic of its Natural Substrate

Marina Bukhtiyarova, Christopher J Rizzo, Charles A Kettner [...]

Antiviral Chemistry and Chemotherapy

Free access

Review article

First published 2013-5

Review of Drug Interactions with Telaprevir and Antiretrovirals

Rolf PG Van Heeswijk, Maria Beumont, Robert S Kauffman [...]

Antiviral Therapy

Free access

Announcement

First published 2015-11

Baseline Prevalence and Emergence of Protease Inhibitor Resistance Mutations following Treatment in Chronic HCV Genotype-1-Infected Individuals

Linh Thuy Nguyen, Emma Gray, Jonathan Dean [...]

Antiviral Therapy

Free access

Review article

First published 2017-1

Grazoprevir/elbasvir combination therapy for HCV infection

Anaïs Vallet-Pichard, Stanislas Pol

Therapeutic Advances in Gastroenterology

Free access

Research article

First published 2006-10

Resistance of Hepatitis C Virus to Ns3–4A Protease Inhibitors: Mechanisms of Drug Resistance Induced by R155Q,A156T,D168A and D168V Mutations

Jérôme Courcambeck, Mourad Bouzidi, Régis Perbost [...]

Antiviral Therapy

Search results